Blurry street background

History

Our legacy, our leadership.

Ongoing Commitment to creating a world where cancer can’t hide. 

iCAD delivered the first complete portfolio of FDA-cleared, clinically-proven cancer detection, density assessment, and risk evaluation solutions, offering a 360-degree approach, expertly designed to accelerate cancer detection and improve outcomes.

And we’re only getting started…

Simling woman in a leather jacket
ProFound AI® Suite 

What’s next?

Next generation detection, density, and risk solutions.

041 – AI Networking Created with Sketch.

Smartest AI

4th gen has 2x training dataset with deep learning AI, compared to 3rd gen AI.

86 -Target- (badge, army, military, war, soldier, retro) Created with Sketch.

Detect cancer even more accurately

Improved AUC. Improved specificity.

007 – Mammogram Created with Sketch.

Compare to prior scans

Provides improved performance in today’s reading.

012 – Money Created with Sketch.

Smart financial decision

Strong ROI for increased efficiency, fewer recalls, and greater confidence with an all-in-one suite for detection, density, and risk.

065 – Layer Selection Created with Sketch.

Flexible deployment

Expanded implementation choices for on-premises, docker support, and cloud.

048 – AI Idea Sharing Created with Sketch.

Continuous innovation

Committed to continuously exploring new mammography insights to help save lives.

  1. 2024

    ProFound AI® Suite

    Released ProFound AI 3.0 service pack, which improves workstation readability through color-coded lesions and scorecard and limiting marks per 3D view.

    Strategic New Partnerships

    Densitas, CancerIQ, RAD-AID. Improving the end-to-end breast health care journey, from quality images, quality detection, and risk assessment.

  2. 2023

    Strategic New Partnerships:

    Google Health, Radiology Partners, Solis Mammography – bringing the best in mammography AI to women across the globe.

  3. 2021

    Enhanced entire suite of detection, density, and risk solutions, improving on the already high-performing, concurrent-reading workflow solution that rapidly analyzes each tomosynthesis image with unparalleled accuracy.

    ProFound AI® Suite

    Includes ProFound AI 3.0, ProFound Risk DBT 2.0, PowerLook Density 4.0 and PowerLook hybrid cloud/enterprise: 3° generation ProFound DBT and FFDM®,  and introduced ProFound Risk 1-Yr assessment

  4. 2019

    Introduced early risk detection, finding the early warning indicators before they are visible.

    ProFound AI® Suite

    Includes ProFound AI Risk 1.0, PowerLook Density 3.4.2 and PowerLook 10.1: Introduced ProFound AI Risk 2-Yr assessment, 2D image-based risk

  5. 2016

    Introduced early detection for 3D DBT mammography built on artificial intelligence.

    PowerLook® Tomo Detection 1.0

    First generation DBT AI for cancer detection: GE® exclusive
    Re-branded as ProFound AI® detection

  6. 2015

    Introduced Breast Density assessments and scoring.

    iReveal® Breast Density Analysis Solution

    Introduced iReveal® Breast Density Analysis Solution, assisting radiologists in evaluating and scoring breast density to identify patients needing supplemental screening.

  7. 2010

    SecondLook 7.2 approved and new branding introduced, PowerLook®

  8. 2002

    Inception of computer-aided breast cancer detection with the MammoReader, kicking off our dedication to productivity and workflow benefits for radiologists.

    SecondLook® Digital

    First 2D Mammography system FDA approved solution.

  9. 2001

    The Revolution began… specializing in computer-aided detection for healthcare, we changed our name to iCAD.

Smiling woman in a jacket
Together, we shine a spotlight on breast cancer.

Creating a world where cancer can’t hide.

At iCAD, we create world-class, leading-edge solutions that empower clinicians and enhance patient care. Our mission is to deliver transformative innovations and revolutionize the future of breast cancer detection, and we will continue to work passionately to provide precise, powerful solutions that are expertly engineered to optimize operational efficiency, clinician confidence, and improve patient outcomes.

Learn more about us.